Product Description
Dronabinol is used to treat nausea and vomiting caused by chemotherapy in people who have already taken other medications to treat this type of nausea and vomiting without good results. Dronabinol is also used to treat loss of appetite and weight loss in people who have acquired immunodeficiency syndrome (AIDS). (Sourced from: https://medlineplus.gov/druginfo/meds/a607054.html)
Mechanisms of Action: CB1 Agonist,CB2 Agonist
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral,Intravenous
FDA Designation: None *
Approval Status: Approved
Approved Countries: Australia | Austria | Belgium | Brazil | Bulgaria | Canada | Chile | Colombia | Croatia | Denmark | Dominican Republic | Egypt | Finland | France | Germany | Greece | Hong Kong | Hungary | India | Indonesia | Ireland | Italy | Morocco | Netherlands | New Zealand | Norway | Pakistan | Peru | Philippines | Portugal | Russia | Slovenia | South Africa | Spain | Taiwan | Turkey | United Arab Emirates | United Kingdom | United States
Approved Indications: Oncology Unspecified | Anorexia | Weight Loss | HIV Infections | Cholestasis
Known Adverse Events: Abdominal Pain | Dizziness | Pain Unspecified | Bradycardia | Apnea
Company: Bionorica SE
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic: Australia, Austria, Colombia, Germany, Netherlands
Active Clinical Trial Count: 9
Highest Development Phases
Phase 3: Chronic Obstructive Pulmonary Disease|Dyspnea|Healthy Volunteers|Marijuana Abuse|Pancreatic Cancer|Pancreatitis, Acute
Phase 2: Cancer Pain|Chronic Pain|Multiple Sclerosis|Neuropathic Pain|Stress Disorders, Post-Traumatic
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
|---|---|---|---|---|---|
| BONG | P3 |
Not yet recruiting |
Dyspnea|Chronic Obstructive Pulmonary Disease|Marijuana Abuse |
2026-04-01 |
|
| CHDR2220 | P2 |
Unknown Status |
Chronic Pain|Neuropathic Pain |
2025-12-01 |
|
| REB23-1128 | P2 |
Not yet recruiting |
Multiple Sclerosis |
2025-09-01 |
|
| PLANCTON | P3 |
Active, not recruiting |
Pancreatitis, Acute |
2025-07-09 |